GENETIC-AF (Completed)
A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure
- Medicine
- bucindolol
- Population
- Heart failure
- Phase
- IIb-IIIa
- Starting year
- 2016
- More information
- ClinicalTrials.gov